MetLife (MET) is a publicly traded Financial Services sector company. As of July 5, 2026, MET trades at $90.06 with a market cap of $57.95B and a P/E ratio of 17.32. MET moved +3.28% today. Year to date, MET is +12.89%; over the trailing twelve months it is +12.36%. Its 52-week range spans $65.21 to $90.06. Analyst consensus is strong buy with an average price target of $94.50. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge Fund Bets $5.5B in CDS Shorts on MetLife with $85B Credit Portfolio: Hedge fund manager Lee Robinson has ramped up CDS short positions against major insurers including MetLife, with net notional US insurers’ CDS bets rising to $5.5 billion by May 22. MetLife holds about $85 billion of private fixed-income assets, 95% rated investment grade, raising concerns over potential writedowns.
| Metric | Value |
|---|---|
| Price | $90.06 |
| Market Cap | $57.95B |
| P/E Ratio | 17.32 |
| EPS | $5.20 |
| Dividend Yield | 0.59% |
| 52-Week High | $90.06 |
| 52-Week Low | $65.21 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $77.59B |
| Net Income | $3.62B |
| Gross Margin | 0.00% |
11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $94.50.